Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Patient cohort.

More »

Table 1 Expand

Fig 1.

ROC curves for individual biomarkers.

Benign tumors vs. cancer.

More »

Fig 1 Expand

Table 2.

Normalized protein expression (NPX) values.

Benign tumors vs. cancer, p < 0.05.

More »

Table 2 Expand

Table 3.

AUC for individual biomarkers.

Benign tumors vs. cancer, AUC > 0.7.

More »

Table 3 Expand

Table 4.

Three-biomarker models.

Benign tumors vs. cancer.

More »

Table 4 Expand

Fig 2.

ROC curves for biomarker models.

Benign tumors vs. cancer.

More »

Fig 2 Expand

Table 5.

Biomarker models, LASSO regression.

Benign tumors vs. cancer.

More »

Table 5 Expand

Fig 3.

ROC curves for individual biomarkers.

Benign tumors vs. borderline + cancer.

More »

Fig 3 Expand

Table 6.

Normalized protein expression (NPX) values.

Benign tumors vs. borderline + cancer, p < 0.05.

More »

Table 6 Expand

Table 7.

AUC for individual biomarkers.

Benign tumors vs. borderline + cancer, AUC > 0.7.

More »

Table 7 Expand

Table 8.

Three-biomarker models.

Benign tumors vs. borderline + cancer.

More »

Table 8 Expand

Fig 4.

ROC curves for biomarker models.

Benign tumors versus borderline + cancer.

More »

Fig 4 Expand

Table 9.

Biomarker models, LASSO selection.

Benign tumors vs. borderline + cancer.

More »

Table 9 Expand